Publications Database

Anagnostou E. et al. (2006)

Divalproex versus placebo for the prevention of irritability associated with fluoxetine treatment in autism spectrum disorder.

Journal of Clinical Psychopharmacology

26(4), pp. 444-446

Anagnostou E. et al. (2014)

Intranasal oxytocin in the treatment of autism spectrum disorders: A review of literature and early safety and efficacy data in youth.

Brain Research

pii: S0006-8993(14)00134-6

Read Abstract (New Window)

Anagnostou E. et al. (2012)

Intranasal oxytocin versus placebo in the treatment of adults with autism spectrum disorders: a randomized controlled trial.

Molecular Autism

3(16),

Read Abstract (New Window) Read Full (New Window)

Carpenter L. A. , Soorya L. , Halpern D. (2009)

Asperger's syndrome and high-functioning autism.

Pediatric Annals

38(1), pp.30-35

Hollander E. et al. (2012)

A double-blind placebo-controlled trial of fluoxetine for repetitive behaviors and global severity in adult autism spectrum disorders.

American Journal of Psychiatry

169(3), pp. 292-299.

Read Abstract (New Window)

Hollander E. et al. (2006)

Divalproex sodium vs. placebo in the treatment of repetitive behaviours in autism spectrum disorder.

International Journal of Neuropsycholpharmacology

9(2), pp. 209-213

Read Abstract (New Window)

Hollander E. et al. (2007)

Oxytocin increases retention of social cognition in autism.

Biological Psychiatry

61(4), pp. 498-503

Read Abstract (New Window) Read Full (New Window)

Kerns C. M. et al.

A multisite, multidisciplinary Delphi Consensus study describing 'usual care' intervention strategies for school-age to transition-age youth with autism.

Journal of Clinical Child and Adolescent Psychology

Read Abstract (New Window)

Soorya L. , Hollander E. , Kiarashi J. (2008)

Psychopharmacologic interventions for repetitive behaviors in autism spectrum disorders.

Child and Adolescent Psychiatric Clinics of North America

17(4), pp. 753-771

Read Abstract (New Window)

Soorya L. et al. (2015)

Randomized comparative trial of a social cognitive skills group for children with autism spectrum disorder.

Journal of the American Academy of Child and Adolescent Psychiatry

March, 54(3), pp. 208-216.

Read Abstract (New Window)

Wasserman S. et al. (2006)

Levetiracetam versus placebo in childhood and adolescent autism: a double-blind placebo-controlled study.

International Clinical Psychopharmacology

21(6), pp. 363-367

Read Abstract (New Window)